Positive symptoms are associated with clinicians' global impression in treatment-resistant schizophrenia

Jimmy Lee, Gagan Fervaha, Hiroyoshi Takeuchi, Valerie Powell, Gary Remington

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Previous investigations on the relationship between global rating measures and symptoms have not considered the additional role of functioning. In this naturalistic study, we examined the relationship between symptom domains and functioning on Clinical Global Impression scales for severity (CGI-S) and improvement (CGI-I) in a sample of patients with schizophrenia assessed to be treatment resistant. Participants were patients with a diagnosis of schizophrenia or schizoaffective disorder who failed 2 prior antipsychotic trials and were considered candidates for clozapine. Theywere assessed on the 18-item Brief Psychiatric rating Scale (BPRS), Social Occupational Functioning Assessment Scale (SOFAS), and CGI-S at baseline. A subset of patients was followed up at 6 weeks after initiation of clozapine and assessed on the CGI-I. The independent effects of symptom domains and functioning on the CGI scales were examined viamultivariate regressionmodels. Brief Psychiatric rating Scale positive factor (P < 0.001) and SOFAS (P < 0.001) scores were significant determinants of CGI-S at baseline. Multivariate models suggested that relative change measures had a better fit for the CGI-I compared to absolute change measures (R2 = 0.72 vs R2 = 0.61, respectively). Improvements in BPRS positive (P < 0.001) and affect (P = 0.002) factors and SOFAS (P = 0.030) scores were significant determinants of CGI-I. Ratings of 1 and 2 on the CGI-I corresponded to a mean relative change in the BPRS total of 65% and 41%, respectively. Positive symptoms were a key determinant of clinicians' impression of severity and improvement in this study. Although psychosocial functioning played a large part in determining severity, it was not as significant in the assessment of improvement.

Original languageEnglish
Pages (from-to)237-241
Number of pages5
JournalJournal of Clinical Psychopharmacology
Volume35
Issue number3
DOIs
Publication statusPublished - 2015 Jun 13

Fingerprint

Brief Psychiatric Rating Scale
Schizophrenia
Clozapine
Therapeutics
Psychotic Disorders
Antipsychotic Agents

Keywords

  • Brief Psychiatric Rating Scale (BPRS)
  • Clinical Global Impression-Improvement (CGI-I)
  • Clinical Global Impression-Severity (CGI-S)
  • clozapine
  • Treatment-resistant schizophrenia

ASJC Scopus subject areas

  • Medicine(all)
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Positive symptoms are associated with clinicians' global impression in treatment-resistant schizophrenia. / Lee, Jimmy; Fervaha, Gagan; Takeuchi, Hiroyoshi; Powell, Valerie; Remington, Gary.

In: Journal of Clinical Psychopharmacology, Vol. 35, No. 3, 13.06.2015, p. 237-241.

Research output: Contribution to journalArticle

Lee, Jimmy ; Fervaha, Gagan ; Takeuchi, Hiroyoshi ; Powell, Valerie ; Remington, Gary. / Positive symptoms are associated with clinicians' global impression in treatment-resistant schizophrenia. In: Journal of Clinical Psychopharmacology. 2015 ; Vol. 35, No. 3. pp. 237-241.
@article{bee73441c1fa474283d94b337248de06,
title = "Positive symptoms are associated with clinicians' global impression in treatment-resistant schizophrenia",
abstract = "Previous investigations on the relationship between global rating measures and symptoms have not considered the additional role of functioning. In this naturalistic study, we examined the relationship between symptom domains and functioning on Clinical Global Impression scales for severity (CGI-S) and improvement (CGI-I) in a sample of patients with schizophrenia assessed to be treatment resistant. Participants were patients with a diagnosis of schizophrenia or schizoaffective disorder who failed 2 prior antipsychotic trials and were considered candidates for clozapine. Theywere assessed on the 18-item Brief Psychiatric rating Scale (BPRS), Social Occupational Functioning Assessment Scale (SOFAS), and CGI-S at baseline. A subset of patients was followed up at 6 weeks after initiation of clozapine and assessed on the CGI-I. The independent effects of symptom domains and functioning on the CGI scales were examined viamultivariate regressionmodels. Brief Psychiatric rating Scale positive factor (P < 0.001) and SOFAS (P < 0.001) scores were significant determinants of CGI-S at baseline. Multivariate models suggested that relative change measures had a better fit for the CGI-I compared to absolute change measures (R2 = 0.72 vs R2 = 0.61, respectively). Improvements in BPRS positive (P < 0.001) and affect (P = 0.002) factors and SOFAS (P = 0.030) scores were significant determinants of CGI-I. Ratings of 1 and 2 on the CGI-I corresponded to a mean relative change in the BPRS total of 65{\%} and 41{\%}, respectively. Positive symptoms were a key determinant of clinicians' impression of severity and improvement in this study. Although psychosocial functioning played a large part in determining severity, it was not as significant in the assessment of improvement.",
keywords = "Brief Psychiatric Rating Scale (BPRS), Clinical Global Impression-Improvement (CGI-I), Clinical Global Impression-Severity (CGI-S), clozapine, Treatment-resistant schizophrenia",
author = "Jimmy Lee and Gagan Fervaha and Hiroyoshi Takeuchi and Valerie Powell and Gary Remington",
year = "2015",
month = "6",
day = "13",
doi = "10.1097/JCP.0000000000000310",
language = "English",
volume = "35",
pages = "237--241",
journal = "Journal of Clinical Psychopharmacology",
issn = "0271-0749",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Positive symptoms are associated with clinicians' global impression in treatment-resistant schizophrenia

AU - Lee, Jimmy

AU - Fervaha, Gagan

AU - Takeuchi, Hiroyoshi

AU - Powell, Valerie

AU - Remington, Gary

PY - 2015/6/13

Y1 - 2015/6/13

N2 - Previous investigations on the relationship between global rating measures and symptoms have not considered the additional role of functioning. In this naturalistic study, we examined the relationship between symptom domains and functioning on Clinical Global Impression scales for severity (CGI-S) and improvement (CGI-I) in a sample of patients with schizophrenia assessed to be treatment resistant. Participants were patients with a diagnosis of schizophrenia or schizoaffective disorder who failed 2 prior antipsychotic trials and were considered candidates for clozapine. Theywere assessed on the 18-item Brief Psychiatric rating Scale (BPRS), Social Occupational Functioning Assessment Scale (SOFAS), and CGI-S at baseline. A subset of patients was followed up at 6 weeks after initiation of clozapine and assessed on the CGI-I. The independent effects of symptom domains and functioning on the CGI scales were examined viamultivariate regressionmodels. Brief Psychiatric rating Scale positive factor (P < 0.001) and SOFAS (P < 0.001) scores were significant determinants of CGI-S at baseline. Multivariate models suggested that relative change measures had a better fit for the CGI-I compared to absolute change measures (R2 = 0.72 vs R2 = 0.61, respectively). Improvements in BPRS positive (P < 0.001) and affect (P = 0.002) factors and SOFAS (P = 0.030) scores were significant determinants of CGI-I. Ratings of 1 and 2 on the CGI-I corresponded to a mean relative change in the BPRS total of 65% and 41%, respectively. Positive symptoms were a key determinant of clinicians' impression of severity and improvement in this study. Although psychosocial functioning played a large part in determining severity, it was not as significant in the assessment of improvement.

AB - Previous investigations on the relationship between global rating measures and symptoms have not considered the additional role of functioning. In this naturalistic study, we examined the relationship between symptom domains and functioning on Clinical Global Impression scales for severity (CGI-S) and improvement (CGI-I) in a sample of patients with schizophrenia assessed to be treatment resistant. Participants were patients with a diagnosis of schizophrenia or schizoaffective disorder who failed 2 prior antipsychotic trials and were considered candidates for clozapine. Theywere assessed on the 18-item Brief Psychiatric rating Scale (BPRS), Social Occupational Functioning Assessment Scale (SOFAS), and CGI-S at baseline. A subset of patients was followed up at 6 weeks after initiation of clozapine and assessed on the CGI-I. The independent effects of symptom domains and functioning on the CGI scales were examined viamultivariate regressionmodels. Brief Psychiatric rating Scale positive factor (P < 0.001) and SOFAS (P < 0.001) scores were significant determinants of CGI-S at baseline. Multivariate models suggested that relative change measures had a better fit for the CGI-I compared to absolute change measures (R2 = 0.72 vs R2 = 0.61, respectively). Improvements in BPRS positive (P < 0.001) and affect (P = 0.002) factors and SOFAS (P = 0.030) scores were significant determinants of CGI-I. Ratings of 1 and 2 on the CGI-I corresponded to a mean relative change in the BPRS total of 65% and 41%, respectively. Positive symptoms were a key determinant of clinicians' impression of severity and improvement in this study. Although psychosocial functioning played a large part in determining severity, it was not as significant in the assessment of improvement.

KW - Brief Psychiatric Rating Scale (BPRS)

KW - Clinical Global Impression-Improvement (CGI-I)

KW - Clinical Global Impression-Severity (CGI-S)

KW - clozapine

KW - Treatment-resistant schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=84929172249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929172249&partnerID=8YFLogxK

U2 - 10.1097/JCP.0000000000000310

DO - 10.1097/JCP.0000000000000310

M3 - Article

VL - 35

SP - 237

EP - 241

JO - Journal of Clinical Psychopharmacology

JF - Journal of Clinical Psychopharmacology

SN - 0271-0749

IS - 3

ER -